RCE Ann: Phase I Clinical Trial R327 Advances to 4000mg - 20th May 2022, 9:54am

annb0t

annb0t

Top 20
RCE Ann: Phase I Clinical Trial R327 Advances to 4000mg
Price Sensitive: Y
Date: 20th May 2022, 9:54am

>>> Read announcement: Google: RCE Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
RCE Ann: Next Dose Cleared in Rapid Infusion Phase I/II UTI Trial - 28th Aug 2023, 1:50pm
Replies
0
Views
139
annb0t
annb0t
annb0t
RCE Ann: Phase I/II Burn Wound Infection Trial Stage 1 Complete - 21st Aug 2023, 12:42pm
Replies
0
Views
97
annb0t
annb0t
annb0t
RCE Ann: Scientia Completes Cohort Dosing in Phase I/II UTI Trial - 28th Jul 2023, 10:20am
Replies
0
Views
138
annb0t
annb0t
annb0t
RCE Ann: Scientia Doses Ahead of Schedule in Phase I/II UTI Trial - 24th Jul 2023, 1:42pm
Replies
0
Views
110
annb0t
annb0t
annb0t
RCE Ann: Phase I Clinical Trial Data Review Complete - 19th Jul 2023, 10:08am
Replies
0
Views
88
annb0t
annb0t
Top Bottom